Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Rawee Ruangkanchanasetr is a leading expert in stereotactic radiosurgery and radiotherapy, with a focused research portfolio on the treatment of intracranial tumors using advanced robotic systems. His major contributions center on the clinical outcomes of CyberKnife® technology, particularly for complex cranial pathologies. His most cited work, a 2018 study on perioptic tumors treated with hypofractionated stereotactic radiotherapy, has garnered 19 citations and established critical safety and efficacy benchmarks for treating lesions near the optic apparatus. In a 2021 study with 13 citations, Dr. Ruangkanchanasetr provided long-term outcome data for vestibular schwannoma patients treated with both stereotactic radiosurgery and hypofractionated radiotherapy, demonstrating the versatility of frameless robotic systems. His more recent 2023 work on bilateral vestibular schwannomas in neurofibromatosis type 2 patients, though with 4 citations, addresses a rare and challenging patient population, highlighting his commitment to advancing treatment for complex cases. Through these studies, Dr. Ruangkanchanasetr has significantly contributed to the evidence base for non-invasive cranial radiation, offering patients safer, more effective alternatives to traditional surgery. His research continues to shape clinical protocols for stereotactic radiotherapy worldwide.